financetom
Business
financetom
/
Business
/
Reliance Capital's total outstanding debt rises to Rs 20,380 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reliance Capital's total outstanding debt rises to Rs 20,380 cr
Jan 8, 2021 6:41 AM

Reliance Capital Ltd (RCL), part of Anil Ambani-promoted Reliance Group, has said the total outstanding debt rose to Rs 20,379.71 at the end of December 2020. The total debt, including interest, stood at Rs 19,805.7 crore on August 31, 2020. The total financial indebtedness of the listed entity, including short-term and long-term debt and accrued interest, was Rs 20,379.71 crore at the end of December 2020, Reliance Capital said in a regulatory filing on Thursday.

The principal amount due to HDFC Ltd is Rs 523.98 crore and to Axis Bank Rs 100.63 crore, RCL said. The total amount of outstanding borrowings from banks and financial institutions works out to Rs 700.76 crore, including accrued interest up to December 31, the company added. Similarly, another group company Reliance Home Finance said the total outstanding debt was close to Rs 13,000 crore.

Total financial indebtedness of the listed entity, including short-term and long-term debt, stood at Rs 12,943.18 crore at the end of December 31, 2020. This includes principal and interest.

.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exelixis Says US FDA Will Review Supplemental NDA for Prospective Treatment for Pancreatic Tumors in March
Exelixis Says US FDA Will Review Supplemental NDA for Prospective Treatment for Pancreatic Tumors in March
Nov 26, 2024
05:37 PM EST, 11/26/2024 (MT Newswires) -- Exelixis ( EXEL ) said late Tuesday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee will review the supplemental new drug application for the company's cabozantinib drug candidate in March. The advisory committee will review data from a phase 3 trial that showed substantial improvement in progression-free survival in patients...
Stratus Properties Closes Texas Project Refinancing
Stratus Properties Closes Texas Project Refinancing
Nov 26, 2024
05:40 PM EST, 11/26/2024 (MT Newswires) -- Stratus Properties ( STRS ) said late Tuesday it closed a $33 million nonrecourse loan due Dec. 1, 2027, to refinance the construction loan for the Kingwood Place retail project in Texas. The company expects the loan to result in payments and distributions of about $2 million. Stratus said it owns roughly 60%...
P10 Insider Sold Shares Worth $737,424, According to a Recent SEC Filing
P10 Insider Sold Shares Worth $737,424, According to a Recent SEC Filing
Nov 26, 2024
05:33 PM EST, 11/26/2024 (MT Newswires) -- Edwin A. Poston, Director, Member of 10% Owner Group, on November 22, 2024, sold 54,103 shares in P10 (PX) for $737,424. SEC Filing: https://www.sec.gov/Archives/edgar/data/1841968/000095017024131136/xslF345X05/ownership.xml ...
TechTarget Shareholders Approve Informa Tech Deal
TechTarget Shareholders Approve Informa Tech Deal
Nov 26, 2024
05:34 PM EST, 11/26/2024 (MT Newswires) -- TechTarget ( TTGT ) said late Tuesday it received shareholder approval for a deal to combine the company with Informa Tech's digital businesses. The companies expect the deal to close Monday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved